Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

imilecleucel-T

- PMLiVE

Merck Serono joins CAR-T race with $941m Intrexon deal

Will collaborate on therapy to recognise and attack antigens on tumour cells

- PMLiVE

Merck KGaA ‘to promote’ Stefan Oschmann to chief executive

Germanphamra company reportedly set to elevate him to the top job next year

- PMLiVE

Merck KGaA supports Get Tested colorectal cancer campaign

Coincides with the first World Metastatic Colorectal Cancer Day

- PMLiVE

Transforming times at AstraZeneca

Lisa Anson, the company’s UK and Ireland president, on AZ's future direction

Preparing for growth in consumer healthcare

Merck’s Uta Kemmerich-Keil on the company’s consumer health ambitions

- PMLiVE

Senior changes at Merck KGaA

New head of controlling for its healthcare business

- PMLiVE

Biogen Idec enlists son of NFL star for MS campaign

Tyler Campbell’s own career was cut short by neurological disease

- PMLiVE

Galderma removed from list of companies compliant to UK Code

Follows breach of pharma standards

- PMLiVE

Merck: You need to win locally in consumer health

And company says it would consider targeted 'bolt-on' acquisitions

- PMLiVE

Novartis’ Gilenya fails in difficult-to-treat form of MS

Drug no better than placebo as a treatment for primary progressive multiple sclerosis

- PMLiVE

FDA adds rare brain infection link to Tecfidera labelling

Biogen Idec’s MS drug gets safety warning

- PMLiVE

Stratified medicines face uptake challenges in the NHS

But 90% of HCPs believe the area will have a positive impact on the health system

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links